Curaleaf Holdings, Inc. (CURLF) Análisis de Acciones
Solo con fines informativos. No es asesoramiento financiero. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
CURLF representa a Curaleaf Holdings, Inc., una empresa del sector Healthcare con un precio de $ (capitalización de mercado 0). La acción obtiene una puntuación de 53/100, una calificación moderada basada en 9 KPI cuantitativos.
Ultimo analisis: 16 mar 2026Curaleaf Holdings, Inc. (CURLF) Resumen de Asistencia Médica y Tuberías
Curaleaf Holdings, Inc. is a vertically integrated cannabis company in the U.S., operating 134 dispensaries and 26 cultivation sites across 22 states. It offers a range of cannabis products and services, including retail, wholesale, and professional services, positioning itself as a key player in the expanding cannabis market.
Tesis de Inversión
Curaleaf Holdings, Inc. presents a compelling investment case based on its strong market position and growth potential within the expanding U.S. cannabis industry. As of March 16, 2026, key value drivers include the company's extensive retail footprint with 134 dispensaries and 26 cultivation sites, its vertically integrated operations, and its diverse product portfolio. The company's negative P/E ratio of -15.23 and negative ROE of -22.0% indicate potential for improvement as the company scales and optimizes operations. Growth catalysts include the ongoing legalization of cannabis in additional states, increasing consumer acceptance, and expansion of its product offerings. Potential risks include regulatory uncertainties, competition, and the company's high debt-to-equity ratio of 123.42.
Basado en las finanzas de FMP y el análisis cuantitativo
Puntos clave
- Operates 134 dispensaries and 26 cultivation sites across 22 states as of June 16, 2022, demonstrating a significant retail and production footprint.
- Gross Margin of 49.8% indicates strong pricing power and efficient cost management in its operations.
- Market Cap of $1.83B reflects its position as a leading cannabis operator in the United States.
- Debt-to-Equity ratio of 123.42 suggests a highly leveraged capital structure, which could pose risks and opportunities.
- Beta of 1.45 indicates higher volatility compared to the overall market, potentially offering higher returns but also greater risk.
Competidores y Pares
Fortalezas
- Extensive retail network and geographic reach.
- Vertically integrated operations.
- Diverse product portfolio.
- Strong brand recognition.
Debilidades
- High debt-to-equity ratio.
- Negative profitability metrics (P/E, ROE).
- Reliance on regulatory approvals.
- Exposure to fluctuating cannabis prices.
Catalizadores
- Ongoing: Continued state-level legalization of cannabis for medical and recreational use.
- Upcoming: Potential federal cannabis reform, such as banking access or decriminalization.
- Ongoing: Expansion of retail footprint through new dispensary openings.
- Upcoming: Launch of new and innovative cannabis products.
- Ongoing: Strategic acquisitions to expand market presence.
Riesgos
- Potential: Regulatory uncertainties and changes in cannabis laws.
- Ongoing: Intense competition from other cannabis operators.
- Ongoing: Fluctuations in cannabis prices and supply chain disruptions.
- Potential: Difficulty in accessing traditional banking and financial services.
- Potential: Negative public perception and social stigma associated with cannabis.
Oportunidades de crecimiento
- Expansion into New States: As more states legalize cannabis for medical or recreational use, Curaleaf has the opportunity to expand its retail and cultivation operations into these new markets. This geographic expansion can drive significant revenue growth and increase its market share. The timeline for this growth is dependent on the pace of legalization in various states, but represents a substantial long-term opportunity.
- Product Innovation and Development: Curaleaf can drive growth by introducing new and innovative cannabis products to meet evolving consumer preferences. This includes developing new formulations, delivery methods, and product categories, such as edibles, concentrates, and topicals. The company can also focus on developing products with specific health and wellness benefits, targeting a broader customer base. The timeline for product development is ongoing, with new products expected to launch regularly.
- Strategic Acquisitions: Curaleaf can pursue strategic acquisitions to expand its market presence, acquire new technologies, or enter new product categories. Acquisitions can provide access to new markets, customer bases, and intellectual property, accelerating growth and enhancing its competitive position. The timing of acquisitions is opportunistic, depending on market conditions and available targets.
- Increased Retail Footprint: Curaleaf can continue to expand its retail footprint by opening new dispensaries in existing and new markets. This will increase its brand visibility, improve customer access, and drive sales growth. The company can also focus on optimizing its existing retail operations to improve efficiency and profitability. The timeline for retail expansion is ongoing, with new dispensaries planned for strategic locations.
- Development of Branded Products: Curaleaf can strengthen its brand recognition and customer loyalty by developing and marketing its own branded products. This includes creating a portfolio of high-quality cannabis products with distinct branding and marketing strategies. Branded products can command premium pricing and generate higher margins. The timeline for brand development is ongoing, with a focus on building brand equity and customer loyalty.
Oportunidades
- Expansion into new states with legalization.
- Product innovation and development.
- Strategic acquisitions.
- Growth in the CBD market.
Amenazas
- Regulatory uncertainties and changes.
- Intense competition from other cannabis operators.
- Fluctuations in cannabis prices.
- Potential for federal legalization to disrupt the market.
Ventajas competitivas
- Extensive retail network with 134 dispensaries provides a significant competitive advantage.
- Vertically integrated operations ensure quality control and cost efficiency.
- Strong brand recognition and customer loyalty.
- Intellectual property and proprietary cultivation techniques.
Acerca de CURLF
Founded in 2010 and headquartered in Wakefield, Massachusetts, Curaleaf Holdings, Inc. has grown to become a significant player in the United States cannabis industry. The company operates through two segments: Cannabis Operations and Non-Cannabis Operations. The Cannabis Operations segment focuses on the cultivation, processing, and sale of cannabis products through its retail dispensaries and wholesale channels. These products include flowers, pre-rolls, concentrates, edibles, and hemp-based CBD products. The Non-Cannabis Operations segment provides a range of professional services to other cannabis licensees, including cultivation, processing, and retail know-how, along with back-office administration, intellectual property licensing, real estate leasing, and lending facilities. Curaleaf's extensive network includes 134 dispensaries and 26 cultivation sites across 22 states as of June 16, 2022, reflecting its broad geographic reach and commitment to serving both medical and adult-use cannabis markets. The company's vertically integrated business model allows it to control the entire value chain, from cultivation to retail, ensuring product quality and consistency.
Qué hacen
- Cultivates and processes cannabis.
- Manufactures cannabis products including flowers, pre-rolls, concentrates, edibles, and topicals.
- Operates retail dispensaries for direct sales to consumers.
- Engages in wholesale distribution of cannabis products.
- Provides professional services to other cannabis licensees.
- Develops and markets hemp-based CBD products.
Modelo de Negocio
- Vertically integrated operations, controlling the entire value chain from cultivation to retail.
- Generates revenue through the sale of cannabis products in its retail dispensaries.
- Generates revenue through wholesale distribution to other retailers.
- Provides professional services to other cannabis licensees for a fee.
Contexto de la Industria
Curaleaf operates in the rapidly evolving cannabis industry, which is experiencing significant growth due to increasing legalization and changing consumer attitudes. The U.S. cannabis market is highly fragmented and competitive, with numerous players vying for market share. Curaleaf's vertically integrated model and extensive retail network provide a competitive advantage. The industry faces regulatory hurdles and varying state laws, creating both challenges and opportunities for companies like Curaleaf. As of 2026-03-16, the market is trending towards consolidation and increased product innovation.
Clientes Clave
- Medical cannabis patients seeking therapeutic relief.
- Adult-use cannabis consumers for recreational purposes.
- Wholesale customers, including other retailers and dispensaries.
- Other cannabis licensees seeking professional services.
Finanzas
Gráfico e información
Precio de la acción de Curaleaf Holdings, Inc. (CURLF): Price data unavailable
Últimas noticias
-
Washington Post Reported President Trump Expected To Announce A Medicare Pilot Program To Reimburse Patients' CBD Treatments
benzinga · 18 dic 2025
-
'Trump to sign executive order reclassifying marijuana: Officials' -ABC Report
benzinga · 17 dic 2025
-
Hess Midstream Signs $100M Repurchase That Includes Class B Units Of Hess Midstream Operations From chevron Affiliate And Hess Midstream's Class A Shares From Public
benzinga · 5 ago 2025
-
'GOP-Led Congressional Panel Demands Investigation On Biden's Marijuana Rescheduling Process, Citing 'Deviations' And 'Mental Health Hazards'' -Marijuana Moment Report
benzinga · 10 jun 2025
Consenso de analistas
Calificación de Consenso
Recomendaciones agregadas de Compra/Mantener/Vender de Benzinga, Yahoo Finance y Finnhub para CURLF.
Objetivos de Precios
Análisis del precio objetivo de Wall Street para CURLF.
MoonshotScore
¿Qué significa esta puntuación?
El MoonshotScore califica el potencial de crecimiento de CURLF en una escala de 0 a 100 en múltiples factores, incluyendo innovación, disrupción del mercado, salud financiera e impulso.
Últimas Noticias
Washington Post Reported President Trump Expected To Announce A Medicare Pilot Program To Reimburse Patients' CBD Treatments
'Trump to sign executive order reclassifying marijuana: Officials' -ABC Report
Hess Midstream Signs $100M Repurchase That Includes Class B Units Of Hess Midstream Operations From chevron Affiliate And Hess Midstream's Class A Shares From Public
'GOP-Led Congressional Panel Demands Investigation On Biden's Marijuana Rescheduling Process, Citing 'Deviations' And 'Mental Health Hazards'' -Marijuana Moment Report
Liderazgo: Boris Alexis Jordan
CEO
Boris Jordan is a prominent figure in the cannabis industry, known for his extensive experience in international finance and emerging markets. Prior to his role at Curaleaf, Jordan held leadership positions at Renaissance Capital, a leading investment bank in Russia. He has a strong background in investment management and has been instrumental in driving Curaleaf's growth and expansion.
Historial: Under Boris Jordan's leadership, Curaleaf has grown to become one of the largest cannabis companies in the United States. He has overseen significant acquisitions, strategic partnerships, and expansion into new markets. Jordan has also focused on building a strong management team and fostering a culture of innovation and compliance.
Información del mercado OTC de CURLF
The OTC Other tier, where Curaleaf trades, represents the lowest tier of over-the-counter (OTC) markets. Unlike stocks listed on major exchanges like the NYSE or NASDAQ, companies on the OTC Other tier often have limited financial disclosure requirements and may not meet the listing standards of the larger exchanges. This tier typically includes companies with limited operating history, penny stocks, and those facing financial difficulties. Investing in companies on the OTC Other tier carries higher risks due to the lack of regulatory oversight and transparency compared to listed companies.
- Nivel OTC: OTC Other
- Estado de divulgación: Unknown
- Limited financial disclosure increases information asymmetry.
- Lower trading volume can lead to price volatility.
- Higher bid-ask spreads can increase transaction costs.
- Potential for delisting or trading suspensions.
- Increased risk of fraud or manipulation.
- Verify the company's regulatory filings and financial statements.
- Assess the company's management team and track record.
- Evaluate the company's business model and competitive landscape.
- Analyze the company's capital structure and debt levels.
- Monitor trading volume and price volatility.
- Consult with a financial advisor.
- Understand the risks associated with OTC investing.
- Established operations with multiple dispensaries and cultivation sites.
- Presence in multiple states with legal cannabis markets.
- Experienced management team with a track record in the industry.
- Focus on compliance and regulatory adherence.
- Positive media coverage and industry recognition.
Preguntas Comunes Sobre CURLF
¿Cuáles son los factores clave para evaluar CURLF?
Curaleaf Holdings, Inc. (CURLF) actualmente tiene una puntuación IA de 53/100, indicando puntuación moderada. Fortaleza clave: Extensive retail network and geographic reach.. Riesgo principal a monitorear: Potential: Regulatory uncertainties and changes in cannabis laws.. Esto no es asesoramiento financiero.
¿Qué es el MoonshotScore de CURLF?
CURLF actualmente puntúa 53/100 (Grado C) en el MoonshotScore, lo que sugiere calificación moderada. La puntuación evalúa el potencial de crecimiento, la salud financiera, el impulso del mercado y los factores de riesgo en 9 KPIs cuantitativos. Se recalcula diariamente con los últimos datos del mercado. Esta puntuación es solo informativa.
¿Con qué frecuencia se actualizan los datos de CURLF?
Los precios de CURLF se actualizan en tiempo real durante el horario del mercado estadounidense (9:30-16:00 ET, días laborables). Los fundamentales se actualizan después de los informes trimestrales o anuales. Las calificaciones de analistas y las perspectivas de IA se actualizan diariamente. Las noticias se agregan continuamente de fuentes financieras.
¿Qué dicen los analistas sobre CURLF?
La cobertura de analistas para CURLF incluye calificaciones de consenso (compra, mantener, venta), objetivos de precio a 12 meses y estimaciones de ganancias de las principales firmas de investigación. Consulte la sección de Consenso de Analistas en esta página.
¿Cuáles son los riesgos de invertir en CURLF?
Las categorías de riesgo para CURLF incluyen riesgo de mercado, riesgo específico de la empresa (gestión, competencia), riesgo financiero (deuda, consumo de efectivo) y riesgo macroeconómico (tasas, inflación). Un riesgo clave identificado: Potential: Regulatory uncertainties and changes in cannabis laws.. Un beta superior a 1,0 indica mayor volatilidad que el S&P 500. Revise la sección de Factores de Riesgo en esta página. Todas las inversiones conllevan riesgo de pérdida.
¿Cuál es la relación P/E de CURLF?
La relación P/E para CURLF compara el precio actual de la acción con sus ganancias por acción. Un P/E más alto puede indicar expectativas de crecimiento, mientras que un P/E más bajo puede sugerir valor. Consulte la pestaña de Financieros para métricas actuales.
¿Está CURLF sobrevalorada o infravalorada?
Determinar si Curaleaf Holdings, Inc. (CURLF) está sobrevalorada o infravalorada requiere examinar múltiples métricas. Compare los ratios de valoración (P/E, P/S, EV/EBITDA) con pares del sector. Esto no es asesoramiento financiero.
¿Cuál es el rendimiento por dividendo de CURLF?
Curaleaf Holdings, Inc. (CURLF) actualmente no paga un dividendo regular, o los datos de rendimiento no están disponibles. Consulte la pestaña de Financieros para información actual.
Descargo de responsabilidad: Este contenido es solo para fines informativos y no constituye asesoramiento de inversión. Siempre haga su propia investigación y consulte a un asesor financiero.
Recursos Oficiales
Datos proporcionados solo con fines informativos.
- Financial data as of 2026-03-16. OTC market data may have limited availability.